Monitoring of dipeptidyl peptidase-IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy — Results of a pilot study-Reference-Cited by-同舟云学术

Monitoring of dipeptidyl peptidase-IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy — Results of a pilot study

Published:2016-04 Issue:6 Volume:49 Page:458-462
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Hetmańczyk Katarzyna,Bednarska-Makaruk Małgorzata,Kierus Karolina,Murawska-Izdebska Sylwia,Piekutowska-Abramczuk Dorota,Pilch Bożena,Tylki-Szymańska Anna,Ługowska Agnieszka

Funder

Instytut Psychiatrii i Neurologii (Warsaw, Poland)

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference30 articles.

1. The mucopolysaccharidoses;Giugliani,2012

2. Biomarkers for the mucopolysaccharidoses: discovery and clinical utility;Clarke;Mol. Genet. Metab.,2012

3. Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease;di Natale;Biotechnol. Appl. Biochem.,2008

4. Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry;Beesley;Mol. Genet. Metab.,2009

5. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous Activities?;Sedo;Biochim. Biophys. Acta,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases;Diagnostics;2021-02-16

2. A case study of three patients with mucopolysaccharidoses in Hue Central Hospital;SAGE Open Medical Case Reports;2020-01

3. Presentation and treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome);Expert Opinion on Orphan Drugs;2017-03-08